Majority of the IBD patients are unaware of the negative effects of smoking on their condition.
A survey conducted by the University of Montreal Hospital concluded that only half of the Inflammatory Bowel disease patients were aware of the smoking risks associated with their disease. The researchers interviewed 239 patients with two common types of IBD, including 182 people with Crohn’s disease and 77 others with ulcerative colitis, about their diagnosis, symptoms, smoking history and understanding of tobacco use might lead to complications or recurrences.
Majority of the participants were white and female, and they were typically in their 40s. Patients with Crohn’s used more corticosteroids to manage their symptoms and they even had more medical care admissions as compared to patients with ulcerative colitis. However, both divisions equally considered that their disease is well controlled.
About 20 % of the study participants were current smokers and nearly 40 % had quit smoking in the last few years. Moreover, only 10 % of ulcerative colitis patients and less than half of people with Crohn’s could correctly explain about the smoking risks on their conditions.
“People think of Crohn’s disease and ulcerative colitis as ‘bowel only’ and cigarette smoking as causing ‘lung problems’ and look at them separately,” said Dr Miguel Regueiro, head of IBD clinical program at the University of Pittsburgh. “The take-home message for patients with IBD is that smoking can affect their disease,” said Dr Stephanie Ducharme-Benard, lead author of the study.
Inflammatory Bowel disease causes chronic inflammation throughout the gastrointestinal tract, and Crohn’s disease and ulcerative colitis are the most common forms of the disorder. People suffering from Crohn’s have inflamed mucosal lining throughout the entire digestive tract while in ulcerative colitis only the large intestine is affected. IMAGE/phillyvoice.com